SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Thyrocare Technologies informs about analyst meet

03 Dec 2018 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that Shrikant Akolkar, Senior Analyst- Pharma of IIFL Securities would be having a meeting with Sachin Salvi, General Manager-Finance, at the office by 11.00 AM on Tuesday, December 04, 2018. There could be last minute change in the names of Analysts or in the timings and Shrikant Akolkar may be accompanied by some of his colleagues, too. It is also informed that no un-published Price-Sensitive Information will be shared during the above meeting.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

472.20 11.60 (2.52%)
07-May-2026 14:04 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×